ST3GAL1 and pachyonychia congenita: We profiled ST3GAL1 genomic alterations across four PC cohorts (N=2016) and found ST3GAL1 is amplified in ~8% of patients in two hormone dependant PC cohorts and amplified in ~20% of patients in two CRPC cohorts (Fig. 1h)36.